SAN DIEGO, Aug. 17 /PRNewswire/ -- aTyr Pharma announced today that Professor Nancy Ip, Chair Professor of the Department of Biochemistry and Director of the Molecular Neuroscience Center at Hong Kong University of Science and Technology (HKUST), has joined their scientific advisory board. An elected academician of the Chinese Academy of Sciences and recipient of China's highest honor in the natural sciences, the National Natural Sciences award, Prof. Ip is widely respected for her discoveries in neurosciences. Her accomplishments include elucidation of key signaling mechanisms for nerve cells that have resulted in the discovery of potential treatments for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.
aTyr Pharma has discovery candidates for treatment of neurological disorders as well as other indications. These novel, naturally occurring proteins are resectins of tRNA synthetases. According to Jeff Watkins, CEO of aTyr Pharma, "The tRNA synthetases play a fundamental role in protein synthesis, but tRNA synthetases in humans have resected forms ("resectins") which provide additional essential signaling activities. aTyr Pharma has discovered proprietary resectins with neuro-protective activities. Applying Prof. Ip's knowledge and experience in neurosciences will accelerate our understanding and development of aTyr Pharma's novel class of therapeutic proteins, helping us to bring novel treatments for neuronal diseases to the market as quickly as possible."
Professor Paul Schimmel of TSRI and co-founder of aTyr Pharma adds, "Prof. Ip has established a world renowned Center for Molecular Neurosciences at HKUST focused on discovery of new medicines, and we look forward to using her perspectives for understanding the neurobiology of our resectins. In addition to her remarkable discoveries in neuroscience, Prof. Ip brings a passion for promoting science and bio
|SOURCE aTyr Pharma|
Copyright©2009 PR Newswire.
All rights reserved